An interventional study of Prophylactic Mesh in Incisional Hernia, sponsored by Hospital Universitario Fundación Alcorcón. Status unknown. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2019-05-16.
Sponsored by Hospital Universitario Fundación Alcorcón · Not applicable, Interventional, and Prevention
Evaluate the effectiveness of mesh reinforcement in high-risk patients to prevent incisional hernia.
Based on the hypothesis that oncological cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC) is associated with an increased risk of developing Incisional Hernia in the postoperative period, with an expected incidence of 50% at 24 months, we designed a prospective, multicenter and randomized clinical study to demonstrate the utility of the meshes in the prevention of Incisional Hernia, hoping to reduce the incidence to 15% at 24 months.
1,096 studies on the registry are indexed under Hernia; 132 are open to participants now.
This study's planned enrollment of 66 is below the median of 80 across 739 interventional studies indexed under Hernia.
Browse Hernia studies →Hospital Universitario Fundación Alcorcón is the lead sponsor of 9 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patients undergo to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy without prophylactic mesh
Patients undergo to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with prophylactic mesh
Procedure: Prophylactic Mesh
Prophylactic Mesh after closure of the abdominal wall after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Rate of Incisional Hernia
Prevention of Incisional Hernia
Time frame: four years
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in May 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hospital Universitario Fundación Alcorcón